Bio-Rad launches specialty immunoassay controls in Europe
Oct. 9, 2025—Bio-Rad Laboratories has launched its Specialty Immunoassay Plus in Europe.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
Tosoh gets clearance for next-gen GR01 HbA1c analyzer
Oct. 7, 2025—Tosoh Bioscience has received FDA 510(k) clearance for its Tosoh Automated Glycohemoglobin Analyzer HLC 723-GR01, intended for monitoring the long-term blood glucose control of people who have diabetes.
GSI Group acquires GenesisBPS
Oct. 2, 2025—GSI Group Holdings has acquired GenesisBPS, a designer and manufacturer of specialized benchtop blood processing equipment and laboratory consumables.
Siemens introduces drug testing analyzer
Sept. 30, 2025—Siemens Healthineers has introduced the Atellica DT 250 benchtop analyzer, to help identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing.
Streck adds Accellix platform to CD-Chex Plus (RUO) control
Sept. 24, 2025—Accellix and Streck announced a strategic collaboration in which Streck has added the Accellix automated cell phenotyping platform to its CD-Chex Plus (RUO) control.
Roche mass spec test categorized as moderate complexity
Sept. 19, 2025—The Food and Drug Administration has categorized Roche’s Ionify 25-Hydroxy Vitamin D total assay as moderate complexity under the Clinical Laboratory Improvement Amendments of 1988.
Idylla CDx MSI test gets FDA premarket approval
Sept. 18, 2025—Biocartis’ Idylla CDx MSI test, developed in partnership with Bristol Myers Squibb, has received FDA premarket approval.
StatLab launches PiSmart S1 slide printer
Sept. 17, 2025—StatLab Medical Products has launched the PiSmart S1 single hopper slide printer.
Voicebrook, Gestalt offer fully speech-enabled DP solution
Sept. 12, 2025—Voicebrook’s VoiceOver Pro reporting platform now connects with Gestalt’s PathFlow digital pathology platform, giving pathologists the ability to navigate images and create reports entirely by voice.
Guardant, PathGroup partner to expand access to Shield test
Sept. 8, 2025—Guardant Health and PathGroup are partnering to expand access to Guardant’s FDA-approved Shield blood test.